About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ICPT - Intercept Pharmaceut...| Previous Close | $17.26 | Open | $17.29 |
| Volume | 186K | Market Cap | 601.89M |
| Yield | Last Dividend |
| The Daily Biotech Pulse: Minerva, InflaR... | 05/12/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOK... | |
| The Daily Biotech Pulse: FDA Authorizes ... | 05/11/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbV... | |
| Intercept Pharmaceuticals, Inc. (NASDAQ:... | 03/12/21 |
| Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Director Srinivas Akkaraju acquired 147,000 shares of the firm???s stock in a transaction that occurred ... | |
| The Daily Biotech Pulse: Fulgent's Big Q... | 03/05/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) Atr... | |
| The Daily Biotech Pulse: Adcom Test Awai... | 02/26/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 25) Apy... | |
| Intercept Pharmaceuticals Earnings Score... | 02/24/21 |
| Intercept Pharmaceuticals announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself b... | |
| HighTide Therapeutics Appoints Dr. Leigh... | 02/01/21 |
| SHENZHEN, China & ROCKVILLE, Md.--(BUSINESS WIRE)--HighTide Therapeutics Inc. (???HighTide???), a clinical-stage biopharmaceutical company, today anno... | |
| Intercept to Present at the 39th Annual ... | 01/05/21 |
| NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and?... | |
| ICPT Deadline Alert: Bronstein, Gewirtz ... | 01/03/21 |
| Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. and certain o... | |
| ICPT Deadline Alert: Bronstein, Gewirtz ... | 01/03/21 |
| NEW YORK???(BUSINESS WIRE)???Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Intercept Pharma... | |
| SHAREHOLDER ALERT: Pomerantz Law Firm Re... | 01/02/21 |
| NEW YORK, Jan. 2, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. and ... | |
| DEADLINE ALERT: Bragar Eagel & Squire, P... | 01/01/21 |
| Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the ... | |
| ICPT FINAL DEADLINE MONDAY: ROSEN, GLOBA... | 01/01/21 |
| NEW YORK, Jan. 01, 2021 (GLOBE NEWSWIRE) ??? Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Phar... | |
| The Law Offices of Frank R. Cruz Reminds... | 12/30/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $ICPT #classaction--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsui... | |
| DEADLINE ALERT: Bragar Eagel & Squire, P... | 12/28/20 |
| NEW YORK--(BUSINESS WIRE)-- #ClassAction--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a c... | |
| ROSEN, A TOP RANKED LAW FIRM, Reminds In... | 12/24/20 |
| NEW YORK, Dec. 24, 2020 (GLOBE NEWSWIRE) ??? Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Phar... | |
| Pomerantz Law Firm Announces the Filing ... | 12/19/20 |
| NEW YORK, Dec. 19, 2020 (GLOBE NEWSWIRE) ??? Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc... | |
| H.C. Wainwright Stick to Their Hold Rati... | 12/11/20 |
| H.C. Wainwright Stick to Their Hold Rating for Intercept Pharma | |
| Chardan Capital Stick to Their Buy Ratin... | 12/11/20 |
| Chardan Capital Stick to Their Buy Rating for Intercept Pharma | |
| ICPT INVESTOR DEADLINE ALERT: Bernstein ... | 12/10/20 |
| NEW YORK, Dec. 10, 2020 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file... | |
| ROSEN, GLOBAL INVESTOR COUNSEL, Reminds ... | 12/07/20 |
| NEW YORK, Dec. 7, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceut... | |
| ICPT INVESTOR FILING DEADLINE: Bernstein... | 12/05/20 |
| NEW YORK, Dec. 05, 2020 (GLOBE NEWSWIRE) ??? Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to... | |
| ROSEN, TRUSTED INVESTOR COUNSEL, Reminds... | 12/05/20 |
| NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. ... | |
| ROSEN, A LEADING INVESTOR RIGHTS LAW FIR... | 12/03/20 |
| NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) ??? Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Phar... | |
| Bragar Eagel & Squire, P.C. Reminds Inve... | 12/02/20 |
| NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) ??? Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that ... | |
| ROSEN, GLOBAL INVESTOR COUNSEL, Reminds ... | 11/26/20 |
| NEW YORK, Nov. 26, 2020 (GLOBE NEWSWIRE) ??? Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Phar... | |
| ROSEN, A LEADING LAW FIRM, Reminds Inter... | 11/24/20 |
| NEW YORK, Nov. 24, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceu... | |
| ROSEN, GLOBALLY RECOGNIZED INVESTOR COUN... | 11/20/20 |
| NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. ... | |
| Bragar Eagel & Squire, P.C. Reminds Inve... | 11/18/20 |
| NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) ??? Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that ... | |
| ICPT Shareholder Alert: Bronstein, Gewir... | 11/17/20 |
| NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Intercept Pharmace... | |
| Hold rating | 03/12/21 |
| HC Wainwright & Co. upgrades from Sell to Neutral rating and lowers Price Target from $25.00 to $21.00 | |
| Buy rating | 03/02/21 |
| Needham maintains Buy rating and lowers Price Target from $80.00 to $34.00 | |
| Strong Buy rating | 03/01/21 |
| Wedbush maintains Outperform rating and lowers Price Target from $106.00 to $88.00 | |
| Strong Buy rating | 02/26/21 |
| Raymond James maintains Outperform rating and lowers Price Target from $60.00 to $52.00 | |
| Sell rating | 02/23/21 |
| HC Wainwright & Co. downgrades from Neutral to Sell rating and announces Price Target of $25.00 | |
| Date | 2021-02-25 (BMO) | Est. (EPS/Rev.) | ($1.47)/ 85.01M |
| Actual (EPS/Rev.) | $-1.58/ $83.27 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Swing it | Lee | 82.00 % | Follow |
| Option Ripper | Option Ripper | 34.00 % | Follow |
| Biotechnology | Robert Gadimian | 26.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
